Global Gene Therapy Products Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Gene Therapy Products market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Gene Therapy Products industry chain, the market status of Cancer (Ex vivo, In Vivo), Monogenic (Ex vivo, In Vivo), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Gene Therapy Products.

Regionally, the report analyzes the Gene Therapy Products markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Gene Therapy Products market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Gene Therapy Products market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Gene Therapy Products industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Ex vivo, In Vivo).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Gene Therapy Products market.

Regional Analysis: The report involves examining the Gene Therapy Products market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Gene Therapy Products market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Gene Therapy Products:
Company Analysis: Report covers individual Gene Therapy Products manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Gene Therapy Products This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Cancer, Monogenic).

Technology Analysis: Report covers specific technologies relevant to Gene Therapy Products. It assesses the current state, advancements, and potential future developments in Gene Therapy Products areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Gene Therapy Products market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Gene Therapy Products market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Ex vivo
    In Vivo

Market segment by Application
    Cancer
    Monogenic
    Infectious disease
    Cardiovascular disease
    Other

Major players covered
    Bluebird Bio
    Sangamo
    Spark Therapeutics
    Dimension Therapeutics
    Avalanche Bio
    Celladon
    Vical Inc.
    Advantagene

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gene Therapy Products product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Gene Therapy Products, with price, sales, revenue and global market share of Gene Therapy Products from 2019 to 2024.
Chapter 3, the Gene Therapy Products competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gene Therapy Products breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Gene Therapy Products market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Gene Therapy Products.
Chapter 14 and 15, to describe Gene Therapy Products sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Gene Therapy Products
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Gene Therapy Products Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Ex vivo
        1.3.3 In Vivo
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Gene Therapy Products Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Cancer
        1.4.3 Monogenic
        1.4.4 Infectious disease
        1.4.5 Cardiovascular disease
        1.4.6 Other
    1.5 Global Gene Therapy Products Market Size & Forecast
        1.5.1 Global Gene Therapy Products Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Gene Therapy Products Sales Quantity (2019-2030)
        1.5.3 Global Gene Therapy Products Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Bluebird Bio
        2.1.1 Bluebird Bio Details
        2.1.2 Bluebird Bio Major Business
        2.1.3 Bluebird Bio Gene Therapy Products Product and Services
        2.1.4 Bluebird Bio Gene Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Bluebird Bio Recent Developments/Updates
    2.2 Sangamo
        2.2.1 Sangamo Details
        2.2.2 Sangamo Major Business
        2.2.3 Sangamo Gene Therapy Products Product and Services
        2.2.4 Sangamo Gene Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Sangamo Recent Developments/Updates
    2.3 Spark Therapeutics
        2.3.1 Spark Therapeutics Details
        2.3.2 Spark Therapeutics Major Business
        2.3.3 Spark Therapeutics Gene Therapy Products Product and Services
        2.3.4 Spark Therapeutics Gene Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Spark Therapeutics Recent Developments/Updates
    2.4 Dimension Therapeutics
        2.4.1 Dimension Therapeutics Details
        2.4.2 Dimension Therapeutics Major Business
        2.4.3 Dimension Therapeutics Gene Therapy Products Product and Services
        2.4.4 Dimension Therapeutics Gene Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Dimension Therapeutics Recent Developments/Updates
    2.5 Avalanche Bio
        2.5.1 Avalanche Bio Details
        2.5.2 Avalanche Bio Major Business
        2.5.3 Avalanche Bio Gene Therapy Products Product and Services
        2.5.4 Avalanche Bio Gene Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Avalanche Bio Recent Developments/Updates
    2.6 Celladon
        2.6.1 Celladon Details
        2.6.2 Celladon Major Business
        2.6.3 Celladon Gene Therapy Products Product and Services
        2.6.4 Celladon Gene Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Celladon Recent Developments/Updates
    2.7 Vical Inc.
        2.7.1 Vical Inc. Details
        2.7.2 Vical Inc. Major Business
        2.7.3 Vical Inc. Gene Therapy Products Product and Services
        2.7.4 Vical Inc. Gene Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Vical Inc. Recent Developments/Updates
    2.8 Advantagene
        2.8.1 Advantagene Details
        2.8.2 Advantagene Major Business
        2.8.3 Advantagene Gene Therapy Products Product and Services
        2.8.4 Advantagene Gene Therapy Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Advantagene Recent Developments/Updates

3 Competitive Environment: Gene Therapy Products by Manufacturer
    3.1 Global Gene Therapy Products Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Gene Therapy Products Revenue by Manufacturer (2019-2024)
    3.3 Global Gene Therapy Products Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Gene Therapy Products by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Gene Therapy Products Manufacturer Market Share in 2023
        3.4.2 Top 6 Gene Therapy Products Manufacturer Market Share in 2023
    3.5 Gene Therapy Products Market: Overall Company Footprint Analysis
        3.5.1 Gene Therapy Products Market: Region Footprint
        3.5.2 Gene Therapy Products Market: Company Product Type Footprint
        3.5.3 Gene Therapy Products Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Gene Therapy Products Market Size by Region
        4.1.1 Global Gene Therapy Products Sales Quantity by Region (2019-2030)
        4.1.2 Global Gene Therapy Products Consumption Value by Region (2019-2030)
        4.1.3 Global Gene Therapy Products Average Price by Region (2019-2030)
    4.2 North America Gene Therapy Products Consumption Value (2019-2030)
    4.3 Europe Gene Therapy Products Consumption Value (2019-2030)
    4.4 Asia-Pacific Gene Therapy Products Consumption Value (2019-2030)
    4.5 South America Gene Therapy Products Consumption Value (2019-2030)
    4.6 Middle East and Africa Gene Therapy Products Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Gene Therapy Products Sales Quantity by Type (2019-2030)
    5.2 Global Gene Therapy Products Consumption Value by Type (2019-2030)
    5.3 Global Gene Therapy Products Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Gene Therapy Products Sales Quantity by Application (2019-2030)
    6.2 Global Gene Therapy Products Consumption Value by Application (2019-2030)
    6.3 Global Gene Therapy Products Average Price by Application (2019-2030)

7 North America
    7.1 North America Gene Therapy Products Sales Quantity by Type (2019-2030)
    7.2 North America Gene Therapy Products Sales Quantity by Application (2019-2030)
    7.3 North America Gene Therapy Products Market Size by Country
        7.3.1 North America Gene Therapy Products Sales Quantity by Country (2019-2030)
        7.3.2 North America Gene Therapy Products Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Gene Therapy Products Sales Quantity by Type (2019-2030)
    8.2 Europe Gene Therapy Products Sales Quantity by Application (2019-2030)
    8.3 Europe Gene Therapy Products Market Size by Country
        8.3.1 Europe Gene Therapy Products Sales Quantity by Country (2019-2030)
        8.3.2 Europe Gene Therapy Products Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Gene Therapy Products Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Gene Therapy Products Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Gene Therapy Products Market Size by Region
        9.3.1 Asia-Pacific Gene Therapy Products Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Gene Therapy Products Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Gene Therapy Products Sales Quantity by Type (2019-2030)
    10.2 South America Gene Therapy Products Sales Quantity by Application (2019-2030)
    10.3 South America Gene Therapy Products Market Size by Country
        10.3.1 South America Gene Therapy Products Sales Quantity by Country (2019-2030)
        10.3.2 South America Gene Therapy Products Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Gene Therapy Products Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Gene Therapy Products Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Gene Therapy Products Market Size by Country
        11.3.1 Middle East & Africa Gene Therapy Products Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Gene Therapy Products Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Gene Therapy Products Market Drivers
    12.2 Gene Therapy Products Market Restraints
    12.3 Gene Therapy Products Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Gene Therapy Products and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Gene Therapy Products
    13.3 Gene Therapy Products Production Process
    13.4 Gene Therapy Products Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Gene Therapy Products Typical Distributors
    14.3 Gene Therapy Products Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Gene Therapy Products Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Gene Therapy Products Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Bluebird Bio Basic Information, Manufacturing Base and Competitors
    Table 4. Bluebird Bio Major Business
    Table 5. Bluebird Bio Gene Therapy Products Product and Services
    Table 6. Bluebird Bio Gene Therapy Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Bluebird Bio Recent Developments/Updates
    Table 8. Sangamo Basic Information, Manufacturing Base and Competitors
    Table 9. Sangamo Major Business
    Table 10. Sangamo Gene Therapy Products Product and Services
    Table 11. Sangamo Gene Therapy Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Sangamo Recent Developments/Updates
    Table 13. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 14. Spark Therapeutics Major Business
    Table 15. Spark Therapeutics Gene Therapy Products Product and Services
    Table 16. Spark Therapeutics Gene Therapy Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Spark Therapeutics Recent Developments/Updates
    Table 18. Dimension Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 19. Dimension Therapeutics Major Business
    Table 20. Dimension Therapeutics Gene Therapy Products Product and Services
    Table 21. Dimension Therapeutics Gene Therapy Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Dimension Therapeutics Recent Developments/Updates
    Table 23. Avalanche Bio Basic Information, Manufacturing Base and Competitors
    Table 24. Avalanche Bio Major Business
    Table 25. Avalanche Bio Gene Therapy Products Product and Services
    Table 26. Avalanche Bio Gene Therapy Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Avalanche Bio Recent Developments/Updates
    Table 28. Celladon Basic Information, Manufacturing Base and Competitors
    Table 29. Celladon Major Business
    Table 30. Celladon Gene Therapy Products Product and Services
    Table 31. Celladon Gene Therapy Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Celladon Recent Developments/Updates
    Table 33. Vical Inc. Basic Information, Manufacturing Base and Competitors
    Table 34. Vical Inc. Major Business
    Table 35. Vical Inc. Gene Therapy Products Product and Services
    Table 36. Vical Inc. Gene Therapy Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. Vical Inc. Recent Developments/Updates
    Table 38. Advantagene Basic Information, Manufacturing Base and Competitors
    Table 39. Advantagene Major Business
    Table 40. Advantagene Gene Therapy Products Product and Services
    Table 41. Advantagene Gene Therapy Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. Advantagene Recent Developments/Updates
    Table 43. Global Gene Therapy Products Sales Quantity by Manufacturer (2019-2024) & (K Units)
    Table 44. Global Gene Therapy Products Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 45. Global Gene Therapy Products Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 46. Market Position of Manufacturers in Gene Therapy Products, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 47. Head Office and Gene Therapy Products Production Site of Key Manufacturer
    Table 48. Gene Therapy Products Market: Company Product Type Footprint
    Table 49. Gene Therapy Products Market: Company Product Application Footprint
    Table 50. Gene Therapy Products New Market Entrants and Barriers to Market Entry
    Table 51. Gene Therapy Products Mergers, Acquisition, Agreements, and Collaborations
    Table 52. Global Gene Therapy Products Sales Quantity by Region (2019-2024) & (K Units)
    Table 53. Global Gene Therapy Products Sales Quantity by Region (2025-2030) & (K Units)
    Table 54. Global Gene Therapy Products Consumption Value by Region (2019-2024) & (USD Million)
    Table 55. Global Gene Therapy Products Consumption Value by Region (2025-2030) & (USD Million)
    Table 56. Global Gene Therapy Products Average Price by Region (2019-2024) & (US$/Unit)
    Table 57. Global Gene Therapy Products Average Price by Region (2025-2030) & (US$/Unit)
    Table 58. Global Gene Therapy Products Sales Quantity by Type (2019-2024) & (K Units)
    Table 59. Global Gene Therapy Products Sales Quantity by Type (2025-2030) & (K Units)
    Table 60. Global Gene Therapy Products Consumption Value by Type (2019-2024) & (USD Million)
    Table 61. Global Gene Therapy Products Consumption Value by Type (2025-2030) & (USD Million)
    Table 62. Global Gene Therapy Products Average Price by Type (2019-2024) & (US$/Unit)
    Table 63. Global Gene Therapy Products Average Price by Type (2025-2030) & (US$/Unit)
    Table 64. Global Gene Therapy Products Sales Quantity by Application (2019-2024) & (K Units)
    Table 65. Global Gene Therapy Products Sales Quantity by Application (2025-2030) & (K Units)
    Table 66. Global Gene Therapy Products Consumption Value by Application (2019-2024) & (USD Million)
    Table 67. Global Gene Therapy Products Consumption Value by Application (2025-2030) & (USD Million)
    Table 68. Global Gene Therapy Products Average Price by Application (2019-2024) & (US$/Unit)
    Table 69. Global Gene Therapy Products Average Price by Application (2025-2030) & (US$/Unit)
    Table 70. North America Gene Therapy Products Sales Quantity by Type (2019-2024) & (K Units)
    Table 71. North America Gene Therapy Products Sales Quantity by Type (2025-2030) & (K Units)
    Table 72. North America Gene Therapy Products Sales Quantity by Application (2019-2024) & (K Units)
    Table 73. North America Gene Therapy Products Sales Quantity by Application (2025-2030) & (K Units)
    Table 74. North America Gene Therapy Products Sales Quantity by Country (2019-2024) & (K Units)
    Table 75. North America Gene Therapy Products Sales Quantity by Country (2025-2030) & (K Units)
    Table 76. North America Gene Therapy Products Consumption Value by Country (2019-2024) & (USD Million)
    Table 77. North America Gene Therapy Products Consumption Value by Country (2025-2030) & (USD Million)
    Table 78. Europe Gene Therapy Products Sales Quantity by Type (2019-2024) & (K Units)
    Table 79. Europe Gene Therapy Products Sales Quantity by Type (2025-2030) & (K Units)
    Table 80. Europe Gene Therapy Products Sales Quantity by Application (2019-2024) & (K Units)
    Table 81. Europe Gene Therapy Products Sales Quantity by Application (2025-2030) & (K Units)
    Table 82. Europe Gene Therapy Products Sales Quantity by Country (2019-2024) & (K Units)
    Table 83. Europe Gene Therapy Products Sales Quantity by Country (2025-2030) & (K Units)
    Table 84. Europe Gene Therapy Products Consumption Value by Country (2019-2024) & (USD Million)
    Table 85. Europe Gene Therapy Products Consumption Value by Country (2025-2030) & (USD Million)
    Table 86. Asia-Pacific Gene Therapy Products Sales Quantity by Type (2019-2024) & (K Units)
    Table 87. Asia-Pacific Gene Therapy Products Sales Quantity by Type (2025-2030) & (K Units)
    Table 88. Asia-Pacific Gene Therapy Products Sales Quantity by Application (2019-2024) & (K Units)
    Table 89. Asia-Pacific Gene Therapy Products Sales Quantity by Application (2025-2030) & (K Units)
    Table 90. Asia-Pacific Gene Therapy Products Sales Quantity by Region (2019-2024) & (K Units)
    Table 91. Asia-Pacific Gene Therapy Products Sales Quantity by Region (2025-2030) & (K Units)
    Table 92. Asia-Pacific Gene Therapy Products Consumption Value by Region (2019-2024) & (USD Million)
    Table 93. Asia-Pacific Gene Therapy Products Consumption Value by Region (2025-2030) & (USD Million)
    Table 94. South America Gene Therapy Products Sales Quantity by Type (2019-2024) & (K Units)
    Table 95. South America Gene Therapy Products Sales Quantity by Type (2025-2030) & (K Units)
    Table 96. South America Gene Therapy Products Sales Quantity by Application (2019-2024) & (K Units)
    Table 97. South America Gene Therapy Products Sales Quantity by Application (2025-2030) & (K Units)
    Table 98. South America Gene Therapy Products Sales Quantity by Country (2019-2024) & (K Units)
    Table 99. South America Gene Therapy Products Sales Quantity by Country (2025-2030) & (K Units)
    Table 100. South America Gene Therapy Products Consumption Value by Country (2019-2024) & (USD Million)
    Table 101. South America Gene Therapy Products Consumption Value by Country (2025-2030) & (USD Million)
    Table 102. Middle East & Africa Gene Therapy Products Sales Quantity by Type (2019-2024) & (K Units)
    Table 103. Middle East & Africa Gene Therapy Products Sales Quantity by Type (2025-2030) & (K Units)
    Table 104. Middle East & Africa Gene Therapy Products Sales Quantity by Application (2019-2024) & (K Units)
    Table 105. Middle East & Africa Gene Therapy Products Sales Quantity by Application (2025-2030) & (K Units)
    Table 106. Middle East & Africa Gene Therapy Products Sales Quantity by Region (2019-2024) & (K Units)
    Table 107. Middle East & Africa Gene Therapy Products Sales Quantity by Region (2025-2030) & (K Units)
    Table 108. Middle East & Africa Gene Therapy Products Consumption Value by Region (2019-2024) & (USD Million)
    Table 109. Middle East & Africa Gene Therapy Products Consumption Value by Region (2025-2030) & (USD Million)
    Table 110. Gene Therapy Products Raw Material
    Table 111. Key Manufacturers of Gene Therapy Products Raw Materials
    Table 112. Gene Therapy Products Typical Distributors
    Table 113. Gene Therapy Products Typical Customers
List of Figures
    Figure 1. Gene Therapy Products Picture
    Figure 2. Global Gene Therapy Products Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Gene Therapy Products Consumption Value Market Share by Type in 2023
    Figure 4. Ex vivo Examples
    Figure 5. In Vivo Examples
    Figure 6. Global Gene Therapy Products Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 7. Global Gene Therapy Products Consumption Value Market Share by Application in 2023
    Figure 8. Cancer Examples
    Figure 9. Monogenic Examples
    Figure 10. Infectious disease Examples
    Figure 11. Cardiovascular disease Examples
    Figure 12. Other Examples
    Figure 13. Global Gene Therapy Products Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 14. Global Gene Therapy Products Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 15. Global Gene Therapy Products Sales Quantity (2019-2030) & (K Units)
    Figure 16. Global Gene Therapy Products Average Price (2019-2030) & (US$/Unit)
    Figure 17. Global Gene Therapy Products Sales Quantity Market Share by Manufacturer in 2023
    Figure 18. Global Gene Therapy Products Consumption Value Market Share by Manufacturer in 2023
    Figure 19. Producer Shipments of Gene Therapy Products by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 20. Top 3 Gene Therapy Products Manufacturer (Consumption Value) Market Share in 2023
    Figure 21. Top 6 Gene Therapy Products Manufacturer (Consumption Value) Market Share in 2023
    Figure 22. Global Gene Therapy Products Sales Quantity Market Share by Region (2019-2030)
    Figure 23. Global Gene Therapy Products Consumption Value Market Share by Region (2019-2030)
    Figure 24. North America Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
    Figure 25. Europe Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
    Figure 26. Asia-Pacific Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
    Figure 27. South America Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
    Figure 28. Middle East & Africa Gene Therapy Products Consumption Value (2019-2030) & (USD Million)
    Figure 29. Global Gene Therapy Products Sales Quantity Market Share by Type (2019-2030)
    Figure 30. Global Gene Therapy Products Consumption Value Market Share by Type (2019-2030)
    Figure 31. Global Gene Therapy Products Average Price by Type (2019-2030) & (US$/Unit)
    Figure 32. Global Gene Therapy Products Sales Quantity Market Share by Application (2019-2030)
    Figure 33. Global Gene Therapy Products Consumption Value Market Share by Application (2019-2030)
    Figure 34. Global Gene Therapy Products Average Price by Application (2019-2030) & (US$/Unit)
    Figure 35. North America Gene Therapy Products Sales Quantity Market Share by Type (2019-2030)
    Figure 36. North America Gene Therapy Products Sales Quantity Market Share by Application (2019-2030)
    Figure 37. North America Gene Therapy Products Sales Quantity Market Share by Country (2019-2030)
    Figure 38. North America Gene Therapy Products Consumption Value Market Share by Country (2019-2030)
    Figure 39. United States Gene Therapy Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 40. Canada Gene Therapy Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 41. Mexico Gene Therapy Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 42. Europe Gene Therapy Products Sales Quantity Market Share by Type (2019-2030)
    Figure 43. Europe Gene Therapy Products Sales Quantity Market Share by Application (2019-2030)
    Figure 44. Europe Gene Therapy Products Sales Quantity Market Share by Country (2019-2030)
    Figure 45. Europe Gene Therapy Products Consumption Value Market Share by Country (2019-2030)
    Figure 46. Germany Gene Therapy Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. France Gene Therapy Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. United Kingdom Gene Therapy Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 49. Russia Gene Therapy Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 50. Italy Gene Therapy Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 51. Asia-Pacific Gene Therapy Products Sales Quantity Market Share by Type (2019-2030)
    Figure 52. Asia-Pacific Gene Therapy Products Sales Quantity Market Share by Application (2019-2030)
    Figure 53. Asia-Pacific Gene Therapy Products Sales Quantity Market Share by Region (2019-2030)
    Figure 54. Asia-Pacific Gene Therapy Products Consumption Value Market Share by Region (2019-2030)
    Figure 55. China Gene Therapy Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. Japan Gene Therapy Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Korea Gene Therapy Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. India Gene Therapy Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 59. Southeast Asia Gene Therapy Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 60. Australia Gene Therapy Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 61. South America Gene Therapy Products Sales Quantity Market Share by Type (2019-2030)
    Figure 62. South America Gene Therapy Products Sales Quantity Market Share by Application (2019-2030)
    Figure 63. South America Gene Therapy Products Sales Quantity Market Share by Country (2019-2030)
    Figure 64. South America Gene Therapy Products Consumption Value Market Share by Country (2019-2030)
    Figure 65. Brazil Gene Therapy Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 66. Argentina Gene Therapy Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 67. Middle East & Africa Gene Therapy Products Sales Quantity Market Share by Type (2019-2030)
    Figure 68. Middle East & Africa Gene Therapy Products Sales Quantity Market Share by Application (2019-2030)
    Figure 69. Middle East & Africa Gene Therapy Products Sales Quantity Market Share by Region (2019-2030)
    Figure 70. Middle East & Africa Gene Therapy Products Consumption Value Market Share by Region (2019-2030)
    Figure 71. Turkey Gene Therapy Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. Egypt Gene Therapy Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 73. Saudi Arabia Gene Therapy Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 74. South Africa Gene Therapy Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 75. Gene Therapy Products Market Drivers
    Figure 76. Gene Therapy Products Market Restraints
    Figure 77. Gene Therapy Products Market Trends
    Figure 78. Porters Five Forces Analysis
    Figure 79. Manufacturing Cost Structure Analysis of Gene Therapy Products in 2023
    Figure 80. Manufacturing Process Analysis of Gene Therapy Products
    Figure 81. Gene Therapy Products Industrial Chain
    Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 83. Direct Channel Pros & Cons
    Figure 84. Indirect Channel Pros & Cons
    Figure 85. Methodology
    Figure 86. Research Process and Data Source

Companies Mentioned

Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene